Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please consider our Risk Disclosure Notice and ensure that you fully understand the risks involved. 78% of retail investor accounts lose money when trading CFDs and 2.15% of retail investor accounts had positions closed due to margin call, over the last 12 months. 78% of retail investor accounts lose money when trading CFDs, and 2.20% had positions closed due to margin calls over the last 12 months.

Stock of the day

Citigroup

Citigroup has delivered a resilient quarterly result, exceeding profit expectations despite higher costs and heightened political uncertainty.

Video poster image

(AI video summary)

This video was created on 15 January 2026 for IG audiences by ausbiz.

NYSE code: C

Earnings strength tempered by expenses

In its latest quarterly report, Citigroup exceeded profit estimates, although profits fell by 13% in the fourth quarter (Q4) of 2025 due to higher expenses and the sale of its Russian branch. Yet, investment banking fees rose 35% to nearly $1.3 billion, highlighting strong mergers and acquisitions (M&A) performance.

The chief executive officer (CEO) signalled potential headcount reductions for efficiency. Despite solid financials, market reaction remained subdued due to political pressures, such as proposed credit card rate caps by President Trump.

Political uncertainty weighs on sentiment

The debate over a temporary 10% credit card rate cap, coincided with Citigroup's earnings. While the stock nearly doubled from April's lows, some investors remain wary. Federal Reserve (Fed) Chair Jerome Powell's resistance to policy changes is a focal point.

Investment outlook

Considered a high-risk option compared to peers like JPMorgan and Bank of America (BoA), Citigroup’s success hinges on M&A advancements and risk management. Up to $3 trillion in initial public offerings (IPOs) could change the landscape, yet stable returns may lie with BoAor JPMorgan.

Important to know

This information has been prepared by IG, a trading name of IG Australia Pty Ltd. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.

Ready to open an IG account?

Start your trading journey now